Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Jcr Pharmaceuticals Co. Ltd.
Sponsor

Jcr Pharmaceuticals Co. Ltd.

3-19 Kasugacho, 659-0021

About the sponsor

JCR Pharmaceuticals Co. Ltd. focuses on clinical research in Hunter syndrome, with particular attention to mucopolysaccharidosis type II and its impact on both central nervous system and somatic symptoms.

  • Central nervous system involvement
  • Somatic disease manifestations
  • Long-term symptom control

The sponsor’s trial activity in this area also includes assessment of safety and pharmacokinetics in patients with MPS II.

About Specializations

Jcr Pharmaceuticals Co. Ltd. runs clinical trials in conditions such as Mucopolysaccharidosis II, Mucopolysaccharidosis III, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

3 clinical trials

Mucopolysaccharidosis II

Recruiting
InvestigationalNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Pabinafusp Alfa
  • Sponsor:Jcr Pharmaceuticals Co. Ltd.

Mucopolysaccharidosis II

Not recruiting
Registered drugNo placebo
Countries:FranceFrance
  • Participants:0–17 years · 18–64 years
  • Substances:Idursulfase
  • Sponsor:Jcr Pharmaceuticals Co. Ltd.

Mucopolysaccharidosis III

Not recruiting
InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:0–17 years
  • Substances:N-Sulfoglucosamine Sulfohydrolase Fused To A Humanised Monoclonal Antibody Targeting Human Transferrin Receptor
  • Sponsor:Jcr Pharmaceuticals Co. Ltd.

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.